ASTC Astrotech Corporation
Astrotech Corporation, through its subsidiaries, engages in the manufacturing and sale of mass spectrometry and gas chromatography equipment in the United States and internationally. The company owns and licenses the intellectual property related to the Astrotech Mass Spectrometer (AMS) Technology, a platform mass spectrometry technology. It also manufactures TRACER 1000, an explosive trace detectors and narcotic trace detectors for use in security and detection at airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, and law enforcement centers; and develops a series of mass spectrometers, including AgLAB 1000 and AgLAB 1000-D2, used in the hemp and cannabis market. In addition, the company offers BreathTest-1000, a breath analysis tool designed to screen for volatile organic compound metabolites found in a person's breath that could indicate a compromised condition; Pro-Control Maximum Value Processing and Pro-Control 1000-D2 mass spectrometer; and instruments built for environmental testing comprising EN-SCAN Handheld GC, EN-SCAN Fenceline Monitor, and EN-SCAN Rugged Lab GC-MS. The company was formerly known as SPACEHAB, Inc. and changed its name to Astrotech Corporation in 2009. The company was incorporated in 1984 and is based in Austin, Texas.…
Industry Peers
Scientific & Technical InstrumentsKey Statistics
About Astrotech (NASDAQ: ASTC)
›
Astrotech (NASDAQ: ASTC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Scientific & Technical Instruments industry, part of the Technology sector, and reports about 28 employees.
The shares were at 3.500 USD on 20 November 2026, up 10.1% over 52 weeks. Its 52-week range is 1.920 USD to 68.85 USD: the price is 94.9% below the high and 82.3% above the low.
Its market capitalisation is 7.45M USD.
Astrotech reports return on equity of -89.2% and revenue down 42.7% year over year.
It holds more cash than debt, a net cash position of 9.03M USD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.